hsCRP (high-sensitivity C-reactive protein) is a well-established systemic inflammatory marker produced by the liver in response to interleukin-6. Elevated hsCRP levels are associated with chronic inflammatory conditions, including those involving the gut, such as inflammatory bowel disease (IBD) and metabolic syndrome. Gut health—particularly barrier function and the microbiome—influences systemic inflammation. Thus, elevated hsCRP may indicate gut barrier dysfunction ('leaky gut') or dysbiosis, but it is not specific to the gut. Consumer hsCRP tests reliably measure levels, but interpretation requires clinical context, as many factors (infections, stress, smoking) affect values. The evidence linking hsCRP to gut health is largely observational; causal conclusions are limited. Lowering hsCRP through a high-fiber diet, exercise, and stress management may support gut health, but does not replace targeted diagnostics. Overall, hsCRP is a useful but non-specific indicator—not a standalone basis for gut therapies.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-f2332e27c318ef18a4427430